Am J Transplant, Volume 19, Suppl 3 Archives - Page 113 of 214 - ATC Abstracts

2019 American Transplant Congress
Borderline Lesions Following Lymphocyte Depletion: Effect of Treatment
N. Wilson¹, S. Tremblay¹, P. Lee¹, S. Bumb¹, R. R. Alloway¹, J. Kremer², A. R. Shields², E. S. Woodle¹
¹University of Cincinnati, Cincinnati, OH, ²The Christ Hospital, Cincinnati, OH
*Purpose: A consensus does not exist on whether to treat borderline lesions in the renal allograft. Importantly, recent data suggests that borderline lesions confer risk…
2019 American Transplant Congress
Effect of Paricalcitol on Markers of Inflammation in De Novo Renal Transplant Recipients
H. K. Pihlstrøm¹, T. Ueland², A. E. Michelsen², G. Mjøen¹, K. Midtvedt¹, H. Holdaas¹
¹Department of Surgery, Inflammation Medicine and Transplantation, Oslo University Hospital, Oslo, Norway, ²Institiute for Clinical Medicine, University of Oslo, Oslo, Norway
*Purpose: Despite the reduction of systemic inflammation associated with receiving a functioning transplant, markers of inflammation may remain somewhat elevated in renal transplant recipients, and…
2019 American Transplant Congress
Diastolic Blood Pressure Derived from Twenty Four Hour Ambulatory Blood Pressure Monitoring Predicts Survival after Kidney Transplantation
l. Basdeo, H. Wadei, M. Prendergast, M. Mai, C. Oshel, T. Jarmi
Transplant, Mayo Clinic, Jacksonville, FL
*Purpose: Cardiac events remain the leading, long term, cause of death after kidney transplantation. In the general population, 50% of cardiac events are attributed to…
2019 American Transplant Congress
Low Dose Thymoglobulin Has No Disadvantages to Standard Higher Dose: A Report of the Midwest Pediatric Nephrology Consortium
I. Ashoor¹, R. Beyl², C. Gupta³, A. Jain⁴, S. Kiessling⁵, H. Patel⁶, J. Sherbotie⁷, D. J. Weaver Jr⁸, R. Zahr⁹, V. Dharnidharka¹⁰
¹LSU Health, New Orleans, LA, ²Pennington Biomedical Research Center, Baton Rouge, LA, ³Children's National Medical Center, Washington, DC, ⁴Wayne State University, Detroit, MI, ⁵University of Kentucky, Lexington, KY, ⁶Nationwide Children's Hospital, Colombus, OH, ⁷University of Utah SOM, Salt Lake City, UT, ⁸Levine Children's Hospital, Charlotte, NC, ⁹University of Tennessee, Memphis, TN, ¹⁰Washington University, St. Louis, MO
*Purpose: What is not known is whether a lower Thymoglobulin (ATG) induction dose provides safe and effective immunosuppression compared to a “standard” higher dose in…
2019 American Transplant Congress
Are Protocol Biopsies Necessary for Pediatric Renal Transplant Recipients?
E. Allred, E. Ingulli
Pediatrics, UCSD, San Diego, CA
*Purpose: Renal allograft survival indirectly correlates with acute rejection episodes. Subacute rejection is also associated with decreased graft survival. Protocol biopsies (bxs) have been implemented…
2019 American Transplant Congress
Post-Transplant Lymphoproliferative Disorders in Pediatric Renal Transplant Recipients: Case Series of 5 Patients
M. E. Araujo¹, C. Metran¹, R. Cardoso¹, G. Araujo¹, T. De Paula¹, L. Cristofani², M. F. Pereira³, D. David⁴, A. Watanabe¹
¹Pediatric Nephrology, ICr HC FMUSP, São Paulo, Brazil, ²Pediatric Oncology, ICr HC FMUSP, São Paulo, Brazil, ³Pediatric Infectology, ICr HC FMUSP, São Paulo, Brazil, ⁴Anatomopathology, HC FMUSP, São Paulo, Brazil
*Purpose: Post-transplant Lymphoproliferative Disorders (PTLD) after solid organ transplantation is a complication of chronic immunosuppression (IS) and is generally associated with Epstein Barr virus (EBV)…
2019 American Transplant Congress
Are Ureteric Stents a Risk Factor for Bk Virus Activation in Kidney Transplantation?
L. Tran, R. Akiki, A. Gautam
Surgery- Section of Transplant Surgery, Boston University School of Medicine, Boston, MA
*Purpose: Ureteric stents are used in Kidney Transplantation, to reduce the incidence of ureteric leaks. There have been a few studies suggesting that placement of…
2019 American Transplant Congress
The Power of Young Donor Liver; Elixir of Life for Sick Liver Transplant Recipient
J. Kusakabe¹, J. McVey², D. J. Firl², M. Fujiki², F. N. Aucejo², C. Quintini², K. Hashimoto², K. Sasaki²
¹Kyoto University Graduate School of Medicine, Kyoto, Japan, ²Cleveland Clinic Foundation, Department of General Surgery, Digestive Disease Institute, Cleveland Clinic, Cleveland, OH
*Purpose: Young donor organs are known to have significant prognostic benefits in liver transplantation (LT). However, details of short- and long-term prognostic benefits of young…
2019 American Transplant Congress
Liver Circle-Based Allocation: LSAM Modeling Results
D. Schladt¹, T. Weaver¹, J. Pyke¹, A. Herreid¹, B. Thompson¹, B. Kasiske¹, J. Snyder¹, W. Kim², J. Lake³, A. Israni¹, J. Heimbach⁴
¹SRTR, Minneapolis, MN, ²Stanford Univ, Stanford, CA, ³Univ of Minnesota, Minneapolis, MN, ⁴Mayo Clinic, Rochester, MN
*Purpose: On June 25, 2018, the OPTN Board of Directors (BOD) directed the Liver and Intestinal Organ Transplantation Committee to propose changes to policy removing…
2019 American Transplant Congress
Living Donor vs. Deceased Donor Liver Transplantation for Pediatric Patients with Metabolic Liver Disease
G. Gu, Q. Xia
Renji Hospital, Shanghai, China
*Purpose: Liver transplantation has been accepted as the appropriate treatment option for pediatric metabolic liver disease and the most common methods used are LDLT and…